1ST Source Bank Has $1.76 Million Stock Position in iShares Biotechnology ETF $IBB

1ST Source Bank lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.9% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,944 shares of the financial services provider’s stock after selling 717 shares during the period. 1ST Source Bank’s holdings in iShares Biotechnology ETF were worth $1,764,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Brighton Jones LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at about $201,000. Financial Gravity Asset Management Inc. acquired a new stake in iShares Biotechnology ETF during the 1st quarter worth approximately $30,000. Woodside Wealth Management LLC bought a new position in iShares Biotechnology ETF in the first quarter valued at approximately $31,000. Apollon Wealth Management LLC lifted its stake in iShares Biotechnology ETF by 1.1% in the first quarter. Apollon Wealth Management LLC now owns 8,754 shares of the financial services provider’s stock valued at $1,120,000 after buying an additional 96 shares in the last quarter. Finally, SBI Securities Co. Ltd. lifted its position in iShares Biotechnology ETF by 5.2% in the 1st quarter. SBI Securities Co. Ltd. now owns 2,198 shares of the financial services provider’s stock valued at $281,000 after acquiring an additional 108 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.4%

IBB stock opened at $157.72 on Friday. The stock has a 50-day moving average price of $148.73 and a two-hundred day moving average price of $135.66. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $159.79.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.